Portfolio Design Labs’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Hold
1,531
0.04% 212
2026
Q1
$234K Hold
1,531
0.04% 201
2025
Q4
$211K Buy
+1,531
New +$200K 0.03% 195
2025
Q3
Sell
-2,502
Closed -$303K 222
2025
Q2
$303K Sell
2,502
-637
-20% -$71.8K 0.06% 126
2025
Q1
$350K Buy
3,139
+297
+10% +$31.6K 0.07% 140
2024
Q4
$277K Buy
+2,842
New +$303K 0.06% 159

Other funds holding NVS

Portfolio Design Labs's NVS Position: Q2 2026 in Review

Portfolio Design Labs held its Novartis (NVS) position steady in Q2 2026 at 1,531 shares worth $240K. The position accounts for 0.04% of the portfolio, ranked #212.

Portfolio Design Labs first reported a position in NVS in Q4 2024 and has held it in 6 quarters since. The position peaked at $350K in Q1 2025. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Portfolio Design Labs held 1,531 shares of Novartis worth $240K as of Q2 2026.
  • Portfolio Design Labs left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.04% of Portfolio Design Labs's portfolio in Q2 2026, its #212 holding.
  • Portfolio Design Labs first reported a position in Novartis in Q4 2024 and has held it in 6 quarters since.
  • Portfolio Design Labs's Novartis position peaked at $350K in Q1 2025.
  • 1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.